Please take a moment to review the latest ASCO News
- HHS Updates Reporting Requirements, Timeline for Provider Relief Fund Recipients
- ASCO Releases Rapid Guideline Recommendation Update for Certain Patients with Hereditary Breast Cancer
- Parents and Patients Urged to Catch Up on Missed HPV Vaccine Doses to Prevent Future Cancers
- Telemedicine Flexibilities, Including Permission to Cross State Lines, Should Continue After COVID-19
- Participate Now: AMA RUC Survey on Office and Outpatient Consultations, Inpatient and Observation Consultations and Services, Inpatient or Observation Discharge Services, and Prolonged E&M Services
- President Biden’s Full FY 2022 Budget Request Proposes Funding Increase for NIH, NCI, and FDA
- ASCO Congratulates Chiquita Brooks-LaSure on Confirmation as CMS Administrator
- REMS Safety Update on BLINCYTO®
- CMS Reweights 2020 MIPS Cost Category; Apply Now for 2021 MIPS Hardship Exceptions; 2018-2019 Cost Measure Benchmark Files Released
- Support Increased Funding for Cancer Research in Fiscal Year 2022
- ASCO Backs New Bill to Streamline Prior Authorization and Reduce Care Delays
- FDA Grants Accelerated Approval to Amivantamab-vmjw for Metastatic Non-small Cell Lung Cancer
- FDA Approves Nivolumab for Resected Esophageal or GEJ Cancer
- New ASCO Journal Series Examines Disparities in Cancer Care for Black People in the United States
- Biden Administration Reverses Rule Limiting Access to Equitable Cancer Care for Sexual and Gender Minority Community